Sexual violence against women and children in Chinese societies

This article provides a comprehensive overview of the reported patterns of sexual violence against women and children in China. It reviews the prevalence of and risk factors for various types of sexual violence and discusses community knowledge and perceptions of these violent acts. It also critically examines three major problems of sexual violence research in China. First, the diversity of findings and study methods reported by surveys and criminal reports reflects the problems in obtaining accurate figures on the scope of the problem. Second, precautions must be taken in reading studies on Chinese culture-specific risk factors for domestic violence. Third, the study of culture-specific factors should not focus solely on cultural factors in a vacuum but rather, should examine traditional culture in the context of modern societies and consensus international standards of human rights. Recommendations for future research are also discussed. © 2009 Sage Publications.postprin

Measurements of differential production cross sections for a Z boson in association with jets in pp collisions at root s=8 TeV

Peer reviewe

Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017

BACKGROUND: Assessments of age-specific mortality and life expectancy have been done by the UN Population Division, Department of Economics and Social Affairs (UNPOP), the United States Census Bureau, WHO, and as part of previous iterations of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD). Previous iterations of the GBD used population estimates from UNPOP, which were not derived in a way that was internally consistent with the estimates of the numbers of deaths in the GBD. The present iteration of the GBD, GBD 2017, improves on previous assessments and provides timely estimates of the mortality experience of populations globally. METHODS: The GBD uses all available data to produce estimates of mortality rates between 1950 and 2017 for 23 age groups, both sexes, and 918 locations, including 195 countries and territories and subnational locations for 16 countries. Data used include vital registration systems, sample registration systems, household surveys (complete birth histories, summary birth histories, sibling histories), censuses (summary birth histories, household deaths), and Demographic Surveillance Sites. In total, this analysis used 8259 data sources. Estimates of the probability of death between birth and the age of 5 years and between ages 15 and 60 years are generated and then input into a model life table system to produce complete life tables for all locations and years. Fatal discontinuities and mortality due to HIV/AIDS are analysed separately and then incorporated into the estimation. We analyse the relationship between age-specific mortality and development status using the Socio-demographic Index, a composite measure based on fertility under the age of 25 years, education, and income. There are four main methodological improvements in GBD 2017 compared with GBD 2016: 622 additional data sources have been incorporated; new estimates of population, generated by the GBD study, are used; statistical methods used in different components of the analysis have been further standardised and improved; and the analysis has been extended backwards in time by two decades to start in 1950. FINDINGS: Globally, 18·7% (95% uncertainty interval 18·4–19·0) of deaths were registered in 1950 and that proportion has been steadily increasing since, with 58·8% (58·2–59·3) of all deaths being registered in 2015. At the global level, between 1950 and 2017, life expectancy increased from 48·1 years (46·5–49·6) to 70·5 years (70·1–70·8) for men and from 52·9 years (51·7–54·0) to 75·6 years (75·3–75·9) for women. Despite this overall progress, there remains substantial variation in life expectancy at birth in 2017, which ranges from 49·1 years (46·5–51·7) for men in the Central African Republic to 87·6 years (86·9–88·1) among women in Singapore. The greatest progress across age groups was for children younger than 5 years; under-5 mortality dropped from 216·0 deaths (196·3–238·1) per 1000 livebirths in 1950 to 38·9 deaths (35·6–42·83) per 1000 livebirths in 2017, with huge reductions across countries. Nevertheless, there were still 5·4 million (5·2–5·6) deaths among children younger than 5 years in the world in 2017. Progress has been less pronounced and more variable for adults, especially for adult males, who had stagnant or increasing mortality rates in several countries. The gap between male and female life expectancy between 1950 and 2017, while relatively stable at the global level, shows distinctive patterns across super-regions and has consistently been the largest in central Europe, eastern Europe, and central Asia, and smallest in south Asia. Performance was also variable across countries and time in observed mortality rates compared with those expected on the basis of development. INTERPRETATION: This analysis of age-sex-specific mortality shows that there are remarkably complex patterns in population mortality across countries. The findings of this study highlight global successes, such as the large decline in under-5 mortality, which reflects significant local, national, and global commitment and investment over several decades. However, they also bring attention to mortality patterns that are a cause for concern, particularly among adult men and, to a lesser extent, women, whose mortality rates have stagnated in many countries over the time period of this study, and in some cases are increasing

CBP/p300 and muscle differentiation: no HAT, no muscle

Terminal differentiation of muscle cells follows a precisely orchestrated program of transcriptional regulatory events at the promoters of both muscle-specific and ubiquitous genes. Two distinct families of transcriptional co-activators, GCN5/PCAF and CREB-binding protein (CBP)/p300, are crucial to this process. While both possess histone acetyl-transferase (HAT) activity, previous studies have failed to identify a requirement for CBP/p300 HAT function in myogenic differentiation. We have addressed this issue directly using a chemical inhibitor of CBP/p300 in addition to a negative transdominant mutant. Our results clearly demonstrate that CBP/p300 HAT activity is critical for myogenic terminal differentiation. Furthermore, this requirement is restricted to a subset of events in the differentiation program: cell fusion and specific gene expression. These data help to define the requirements for enzymatic function of distinct coactivators at different stages of the muscle cell differentiation program

Dietary Effects of Soy Isoflavones on Growth and Carcass Traits Of Commercial Broilers

Three experiments (EXP) were conducted to determine the effect of soy isoflavones (ISF) on growth and carcass traits of commercial broilers. The EXP were conducted simultaneously and a common control was used. In each EXP, treatments were replicated five times with five chicks each. Average initial and final BW were 102 and 2,890 g, 102 and 2,657 g, and 102 and 2,803 g for EXP 1,2, and 3, respectively, and the EXP were conducted from 9 to 52 d posthatching. In EXP 1, the effects of graded levels of supplemental ISF above those typically found in a corn-soybean meal (C-SBM) diet were studied. The treatments were 1) C-SBM, 2) C-SBM + ISF levels two times those in C-SBM (2×), and 3) C-SBM + ISF levels five times those in C-SBM (5×). The 2× and 5× levels of ISF decreased gain:feed (linear, P \u3c 0.04) but increased (P \u3c 0.04) breast weight compared with the C-SBM diet. Other performance and carcass traits were not affected (P \u3e 0.05) by treatment. In EXP 2, the effects of low ISF levels in a C-soy protein concentrate (C-SPC) diet were studied. The treatments were 1) C-SBM, 2) C-SPC (low ISF), and 3) C-SPC + ISF (ISF levels equal to those in C-SBM). Average daily gain (ADG) and average daily feed intake (ADFI) were decreased (16 and 9%, respectively; P \u3c 0.01) in chicks fed the C-SPC diets, regardless of ISF level. Gain:feed of chicks fed the C-SPC + ISF diet was decreased 9% (P \u3c 0.02) compared with chicks fed the C-SBM diet, and gain:feed of chicks fed C-SPC was intermediate between the two. Carcass traits were not affected (P \u3e 0.05) by treatment. In EXP 3, the effects of low ISF levels in a low CP diet were studied. The treatments were 1) C-SBM, 2) low CP (17,14, and 12% in the starter, growing, and finishing diets, respectively) with supplemental crystalline amino acids (low CP-AA), and 3) low CP-AA + ISF (ISF levels equal to C-SBM). Daily gain and gain:feed were decreased from 7 to 9% (P \u3c 0.01) in chicks fed the low CP-AA and low CP-AA + ISF diet relative to those fed the C-SBM diet. Abdominal fat pad percentage was increased (P \u3c 0.01) in chicks fed the low CP-AA diets compared with those fed the C-SBM diet. Dietary ISF can affect ADG and ADFI and may affect carcass traits in some instances

Glycine Supplementation to Low Protein, Amino Acid-Supplemented Diets Supports Optimal Performance of Broiler Chicks

Six experiments were conducted to determine the effects of low CP in diets for broilers and to evaluate limiting essential and nonessential amino acids (AA) in these diets. All experiments were conducted with Ross x Ross broilers in brooder batteries from 0 to 17 or 18 d posthatch. Treatments were replicated with 6 pens of either 5 or 6 broilers each. In Experiment (Exp.) 1, corn-soybean meal diets were formulated to 16.18, 17.68, 19.18, 20.68, or 22.18% CP. The 22.18% CP diet provided 1.23% Lys and 0.89% TSAA, met or exceeded all nutrient requirements of young broilers, and served as the positive control (PC) diet in all experiments. Increasing dietary CP linearly increased final BW, daily gain (ADG), and gain:feed (G:F) (P \u3c 0.005). In Exp. 2, additions of crystalline essential (EAA) or nonessential AA (NEAA) were added to the low CP diet to simulate the AA profile of the PC. Daily gain, final BW, and G:F were decreased (P \u3c 0.01) when CP was reduced, but the addition of the NEAA increased final BW, ADG, and G:F (P \u3c 0.07) to the level of broilers fed the PC. Addition of EAA alone was without effect. In Exp. 3, chicks fed diets with supplemental Glu, Ala, Asp, or Pro had reduced daily feed intake (ADFI), ADG, and final BW (P \u3c 0.05) compared with the PC diet. Addition of Gly or the combination of Gly, Glu, Asp, Ala, and Pro to the low CP diet increased G:F (P \u3c 0.01) compared with chicks fed PC, and ADG was not different from that of broilers fed the PC diet. In Exp. 4, chicks were fed either the PC diet, the low CP diet with Gly + Ser concentrations of 1.23, 1.35, 1.47, 1.59, 1.71, 1.83, 1.95, or 2.07%, or a 10th diet that contained 1.23% Gly + Ser and with Glu to equal the N concentration of the 2.07% Gly + Ser diet. Final BW, ADG, and G:F were increased linearly (P \u3c 0.001) as the concentration of dietary Gly + Ser was increased. Chicks fed the low CP diet with 2.07% Gly + Ser had growth performance that was not different from that of chicks fed the PC. The addition of Glu to the low CP diet was without effect. In Exp. 5, chicks were fed the PC with additions of 0, 0.15, or 0.30% Gly or the low CP diet containing 1.60, 1.72, 1.84, 1.96, 2.08, 2.20, or 2.32% Gly + Ser. Glycine addition to the PC had no effect, but Gly addition to the low CP diet increased G:F linearly (P \u3c 0.001). Growth performance of chicks fed the low CP diet with 2.32% Gly + Ser was equal to that of chicks fed the PC diet. In Exp. 6, chicks were fed the PC or the low CP diet containing 1.80, 1.95, 2.10, 2.25, 2.40, 2.55, 2.70, 2.85, or 3.00% Gly + Ser. Glycine addition to the low CP diet increased G:F linearly (P \u3c 0.001). In summary, low CP diets result in optimal growth of broilers with Gly + Ser levels of 2.44%. ©2006 Poultry Science Association, Inc